Kevin Williamson - 05 Nov 2024 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role
Chief Financial Officer, Director
Signature
/s/ Kevin Williamson
Issuer symbol
TNON
Transactions as of
05 Nov 2024
Net transactions value
$0
Form type
4
Filing time
19 Dec 2025, 17:38:31 UTC
Previous filing
19 Sep 2024
Next filing
15 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Williamson Kevin Chief Financial Officer, Director 104 COOPER COURT, LOS GATOS /s/ Kevin Williamson 19 Dec 2025 0002037535

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNON Common Stock Options Exercise $0 +2,083 $0.000000 2,083 03 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNON Restricted Stock Units Award $0 +6,250 $0.000000 6,250 05 Nov 2024 Common Stock 6,250 Direct F2, F3, F4
transaction TNON Restricted Stock Units Options Exercise $0 -2,083 -33% $0.000000 4,167 03 Sep 2025 Common Stock 2,083 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025.
F2 Represents a grant of 6,250 RSUs of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 2,083 RSUs on September 3, 2025; 1,041 RSUs on each of March 3, 2026, September 3, 2026, and March 3, 2027; and 1,044 on September 3, 2027.
F3 Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F4 N/A